Formulation Strategies and In Vitro Characterization of Talquetamab-Loaded Nanocarriers for Targeted Immunotherapy in Multiple Myeloma. IJRDT 2026, 4 (1), 41-61. https://doi.org/10.62218/ijrdt.v4i1.166.